1. Home
  2. ETJ vs YDES Comparison

ETJ vs YDES Comparison

Compare ETJ & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

ETJ

Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$8.46

Market Cap

543.8M

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$5.31

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETJ
YDES
Founded
N/A
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
543.8M
543.0M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
ETJ
YDES
Price
$8.46
$5.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
142.1K
19.3K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.88
$4.73
52 Week High
$9.12
$25.00

Technical Indicators

Market Signals
Indicator
ETJ
YDES
Relative Strength Index (RSI) 53.53 41.76
Support Level $8.30 $4.73
Resistance Level $8.58 $8.77
Average True Range (ATR) 0.08 0.26
MACD 0.01 0.11
Stochastic Oscillator 62.96 64.16

Price Performance

Historical Comparison
ETJ
YDES

About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: